Sue-Hwa Lin
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Christopher J. LogothetisJeri KimSong-Chang LinSankar N. MaityGary E. GallickAdel K. El‐NaggarEleni EfstathiouAna M. Aparicio
- Topics
- Prostate Cancer Treatment and Research (12 papers)Bone health and treatments (9 papers)Radiopharmaceutical Chemistry and Applications (7 papers)
- Partner nations
- United StatesNetherlandsSpain
In The Last Decade
Sue-Hwa Lin
23 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 85
- Oncology 638
- Molecular Biology 535
- Pulmonary and Respiratory Medicine 486
- Cancer Research 257
- Radiology, Nuclear Medicine and Imaging 189
Countries citing papers authored by Sue-Hwa Lin
This map shows the geographic impact of Sue-Hwa Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue-Hwa Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue-Hwa Lin more than expected).
Fields of papers citing papers by Sue-Hwa Lin
This network shows the impact of papers produced by Sue-Hwa Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue-Hwa Lin. The network helps show where Sue-Hwa Lin may publish in the future.
Co-authorship network of co-authors of Sue-Hwa Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Sue-Hwa Lin. A scholar is included among the top collaborators of Sue-Hwa Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue-Hwa Lin. Sue-Hwa Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 14 | |
| 3 | 8 | |
| 4 | 179 | |
| 5 | 30 | |
| 6 | 6 | |
| 7 | 21 | |
| 8 | 37 | |
| 9 | 36 | |
| 10 | 56 | |
| 11 | 1 | |
| 12 | 18 | |
| 13 | 28 | |
| 14 | 452 | |
| 15 | 9 | |
| 16 | 28 | |
| 17 | 34 | |
| 18 | 18 | |
| 19 | 12 | |
| 20 | 18 |
About Sue-Hwa Lin
Sue-Hwa Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Bone health and treatments (9 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). The work is most often cited by research in Oncology (638 citations), Cancer Research (257 citations) and Pulmonary and Respiratory Medicine (486 citations). Sue-Hwa Lin has collaborated with scholars based in United States, Netherlands and Spain. Frequent co-authors include Christopher J. Logothetis, Jeri Kim, Song-Chang Lin, Sankar N. Maity, Gary E. Gallick, Adel K. El‐Naggar, Eleni Efstathiou, Ana M. Aparicio, Li‐Yuan Yu‐Lee and Yu-Chen Lee. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature reviews. Cancer and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.